Morgan Stanley analyst Tejas Savant maintained a Buy rating on 10x Genomics (TXG – Research Report) today and set a price target of $26.00. The ...

Barclays lowered the firm’s price target on 10x Genomics (TXG) to $15 from $18 and keeps an Overweight rating on the shares.Maximize Your ...

Biotech company 10x Genomics (NASDAQ:TXG) will be reporting earnings tomorrow after market hours. Here’s what to look for. 10x Genomics missed analysts’ revenue expectations by 5% last quarter, ...

10x Genomics, Inc. (NASDAQ ... check out our report about the cheapest AI stock. READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap.

Biotech company 10x Genomics (NASDAQ:TXG) reported Q4 CY2024 results , but sales fell by 10.3% year on year to $165 million.

Also Read: Donald Trump Has ‘More Than 50%’ Of ... Anthony Pompliano Predicts Why It MattersL While remaining bullish on Bitcoin BTC/USD, 10x Research emphasizes a notable shift in stablecoin ...

This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...

The CEO of OpenAI Sam Altman has penned a personal blog post which admits the short-term of AI may not be much different.

Our rollover betting guide takes a look at what is rollover in betting to see how it's applied to betting bonuses and how ...